tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
GANX
Gain Therapeutics
Overview
Analyst Forecasts
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding GANX?
Track your performance easily
Link Broker

Gain Therapeutics (GANX) Stock News & Sentiment

249 Followers
Gain Therapeutics Appoints New CEO Amidst Clinical Progress
Premium
Company Announcements
Gain Therapeutics Appoints New CEO Amidst Clinical Progress
24d ago
8K
GANX
Gain Therapeutics Advances GT-02287 into Phase 1b Trial
Premium
Company Announcements
Gain Therapeutics Advances GT-02287 into Phase 1b Trial
1M ago
8K
GANX
Gain Therapeutics Advances Parkinson’s Therapy Development
Premium
Company Announcements
Gain Therapeutics Advances Parkinson’s Therapy Development
2M ago
GANX
Is GANX a Buy, Before Earnings?
Premium
Pre-Earnings
Is GANX a Buy, Before Earnings?
3M ago
GANX
Gain Therapeutics Excels in Neurodegenerative Drug Trials
Premium
Company Announcements
Gain Therapeutics Excels in Neurodegenerative Drug Trials
4M ago
8K
GANX
Gain Therapeutics Advances Parkinson’s Treatment in Phase 1
Premium
Company Announcements
Gain Therapeutics Advances Parkinson’s Treatment in Phase 1
7M ago
8K
GANX
Gain Therapeutics Leadership Changes and Executive Compensation
Premium
Company Announcements
Gain Therapeutics Leadership Changes and Executive Compensation
7M ago
8K
GANX
More GANX News >

GANX News on the Web

All You Need to Know About Gain Therapeutics (GANX) Rating Upgrade to Strong Buy
Zacks
Bullish
Best Momentum Stocks to Buy for January 9th
Zacks
Bullish
Gain Therapeutics' GT-02287 study to deliver positive findings, says Roth MKM
The Fly
Neutral
Gain Therapeutics Advances GT-02287 into Phase 1b Trial
TipRanks News
Bullish
Promising Preclinical Data and Financial Position Support Buy Rating for Gain Therapeutics
TipRanks News
Bullish
Optimistic Buy Rating for Gain Therapeutics Driven by Promising GT-02287 Trials
TipRanks News
Bullish
Gain Therapeutics Advances Parkinson’s Therapy Development
TipRanks News
Neutral
Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
GANX
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week99%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GANX’s Media Buzz Sentiment?
Currently, no data Available
What is GANX’s weekly average amount of articles?
Currently, no data Available
What is GANX’s News Sentiment?
99% of articles about GANX were positive this week, compared to its sector average of 64%.
    Healthcare Stocks that are Trending in the News
    LNTHLantheus
    INBSIntelligent Bio Solutions
    AKROAkero Therapeutics
    DVADaVita
    FNAParagon 28
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing